Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1998 Jul;11(3):480-96.
doi: 10.1128/CMR.11.3.480.

Dengue and dengue hemorrhagic fever

D J Gubler  1
Affiliations
Review

Dengue and dengue hemorrhagic fever

D J Gubler. Clin Microbiol Rev. 1998 Jul.

Abstract

Dengue fever, a very old disease, has reemerged in the past 20 years with an expanded geographic distribution of both the viruses and the mosquito vectors, increased epidemic activity, the development of hyperendemicity (the cocirculation of multiple serotypes), and the emergence of dengue hemorrhagic fever in new geographic regions. In 1998 this mosquito-borne disease is the most important tropical infectious disease after malaria, with an estimated 100 million cases of dengue fever, 500,000 cases of dengue hemorrhagic fever, and 25,000 deaths annually. The reasons for this resurgence and emergence of dengue hemorrhagic fever in the waning years of the 20th century are complex and not fully understood, but demographic, societal, and public health infrastructure changes in the past 30 years have contributed greatly. This paper reviews the changing epidemiology of dengue and dengue hemorrhagic fever by geographic region, the natural history and transmission cycles, clinical diagnosis of both dengue fever and dengue hemorrhagic fever, serologic and virologic laboratory diagnoses, pathogenesis, surveillance, prevention, and control. A major challenge for public health officials in all tropical areas of the world is to develop and implement sustainable prevention and control programs that will reverse the trend of emergent dengue hemorrhagic fever.

PubMed Disclaimer

Figures

FIG. 1
FIG. 1
A. aegypti distribution in the Americas during the 1930s and in 1970 and 1998.
FIG. 2
FIG. 2
DHF in the Americas before 1981 and from 1981 to the present.
FIG. 3
FIG. 3
World distribution map of dengue and A. aegypti in 1998.
FIG. 4
FIG. 4
A. aegypti and A. albopictus distribution in the United States in 1998.
FIG. 5
FIG. 5
Transmission cycles of dengue viruses.
See this image and copyright information in PMC

References

    1. Anonymous. Dengue hemorrhagic fever, diagnosis, treatment and control. Geneva, Switzerland: World Health Organization; 1986.
    1. Anonymous. Dengue in the Americas—time to talk. Lancet. 1997;350:455. . (Editorial.) - PubMed
    1. Bancroft W H, Scott R M, Eckels K H, Hoke C H, Simms T E, Jesrani K D T, Summers P L, Dubois D R, Tsoulos D, Russell P K (Editorial.) Dengue virus type 2 vaccine: reactogenicity and immunogenicity in soldiers. J Infect Dis. 1984;149:1005–1010. - PubMed
    1. Barnes W J S, Rosen L. Fatal hemorrhagic disease and shock associated with primary dengue infection on a pacific island. Am J Trop Med Hyg. 1974;23:495–506. - PubMed
    1. Becker Y. Dengue fever virus and Japanese encephalitis virus synthetic peptides, with motifs to fit HLA class I haplotypes prevalent in human populations in endemic regions, can be used for applications to skin Langerhans cells to prime antiviral CD8+ cytotoxic T cells (CTLs)—a novel approach to the protection of humans. Virus Genes. 1994;9:33–45. - PubMed